Table 1.
Outcomes | n/total (%) | P-Value |
---|---|---|
Year | P=0.570 | |
2003 | 22/171 (12.9) | |
2005 | 27/221 (12.2) | |
2007 | 27/273 (9.9) | |
State* | P=0.186 | |
Illinois | 18/143 (12.6) | |
Indiana | 4/81 (4.7) | |
Kentucky | 1/22 (4.3) | |
Michigan | 17/121 (14.0) | |
Ohio | 24/170 (14.1) | |
Wisconsin | 12/123 (9.8) | |
Study Design | P=0.001 | |
Randomized Controlled | 1/20 (5.0) | |
Non-Controlled Interventional | 6/43 (14.0) | |
Non-Randomized Interventional | 4/21 (19.0) | |
Bench | 2/8 (25.0) | |
Cohort | 28/255 (11.0) | |
Case-Control | 2/13 (15.4) | |
Cross-Sectional | 12/106 (11.3) | |
Medication Utilization Evaluation | 5/87 (5.7) | |
Survey | 13/39 (33.3) | |
Systematic Review | 0/1 (0) | |
Service Development | 3/72 (4.2) | |
Study Type | P=0.380 | |
Interventional | 13/92 (14.1) | |
Observational | 63/573 (11.0) | |
Direction of Interest | P=0.130 | |
Prospective | 16/101 (15.8) | |
Retrospective | 60/564 (10.6) | |
Intervention of Interests | P=0.100 | |
Drugs | 26/304 (8.6) | |
Human | 28/206 (13.6) | |
Other | 22/155 (14.2) | |
Results in GLRPC Abstract | P=0.082 | |
Yes | 18/111 (16.2) | |
No | 58/554 (10.5) | |
Institution Type | P=0.002 | |
University-Affiliated | 49/287 (17.1) | |
Veterans Affairs Affiliated | 6/101 (5.9) | |
Community/Retail | 3/24 (12.5) | |
Hospital (non-University/no-VA) | 18/248 (7.3) | |
Other | 0/5 (0) |
May not represent all residency programs/residents within the state
GLRPC = Great Lakes Regional Pharmacy Conference